tiprankstipranks
Trending News
More News >
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
US Market

OrthoPediatrics (KIDS) Earnings Dates, Call Summary & Reports

Compare
113 Followers

Earnings Data

Report Date
Jul 30, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.29
Last Year’s EPS
-0.23
Same Quarter Last Year
Based on 7 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 07, 2025
|
% Change Since: 3.47%
|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive sentiment with significant revenue growth, increased profitability, and successful product approvals. Despite some challenges in international revenue and higher operating expenses, the company remains optimistic about future growth and profitability.
Company Guidance
During the OrthoPediatrics Corporation's first quarter 2025 earnings call, the company provided optimistic guidance for the year, highlighting several key metrics. The company expects full-year revenue to range between $236 million and $242 million, reflecting an annual growth of 15% to 18%. They project adjusted EBITDA of $15 to $17 million, which will surpass the $15 million allocated for set deployments in 2025. The first quarter saw global revenue growth of 17%, with U.S. revenues increasing by 19% and international revenues by 11%. The company also reduced its adjusted EBITDA loss by over 50% year-over-year and improved free cash flow by 36%. OrthoPediatrics anticipates positive free cash flow by the fourth quarter of 2025 and aims for full-year free cash flow breakeven in 2026. The company emphasized its ongoing commitment to expanding its product offerings, with five FDA approvals already received in 2025, and plans for further clinic and territory expansion, particularly in the OPSB sector.
Strong Revenue Growth
OrthoPediatrics reported a global revenue growth of 17% in Q1 2025, driven by trauma, scoliosis, and OPSB segments. U.S. revenue increased by 19%, contributing 78% of the total revenue.
Increased Profitability
The company reduced its adjusted EBITDA loss by more than half year-over-year and improved free cash flow by 36%. Gross profit margin increased to 73% from 72% in the previous year.
Successful Product Approvals
Five FDA approvals were received, including the Verteglide system and 3P pediatric plating platform HIP system, enhancing the product portfolio.
Scoliosis Segment Growth
Scoliosis global revenue increased by 34%, driven by the adoption of Response, Apifix, and 7D technology. New approvals like Verteglide are expected to further enhance growth.
OPSB Clinic Expansion
The OPSB segment showed a growth of over 20% with successful expansion into new territories such as North Carolina, with plans for further expansion.
Positive Future Outlook
The company increased its full-year revenue guidance to $236 million to $242 million, reflecting a growth of 15% to 18%.
---

OrthoPediatrics (KIDS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

KIDS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2025
2025 (Q2)
-0.29 / -
-0.23
May 07, 2025
2025 (Q1)
-0.44 / -0.39
-0.3-30.00% (-0.09)
Mar 04, 2025
2024 (Q4)
-0.30 / -0.29
-0.23-26.09% (-0.06)
Nov 06, 2024
2024 (Q3)
-0.23 / -0.18
-0.13-38.46% (-0.05)
Aug 05, 2024
2024 (Q2)
-0.26 / -0.23
-0.19-21.05% (-0.04)
May 06, 2024
2024 (Q1)
-0.41 / -0.30
-0.29-3.45% (-0.01)
Mar 06, 2024
2023 (Q4)
-0.27 / -0.23
-0.3228.13% (+0.09)
Nov 06, 2023
2023 (Q3)
-0.21 / -0.13
-0.05-160.00% (-0.08)
Jul 31, 2023
2023 (Q2)
-0.20 / -0.19
-0.17-11.76% (-0.02)
May 01, 2023
2023 (Q1)
-0.35 / -0.29
-0.33.33% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

KIDS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2025
$22.18$23.08+4.06%
Mar 04, 2025
$22.89$25.61+11.88%
Nov 06, 2024
$30.95$27.49-11.18%
Aug 05, 2024
$29.04$27.26-6.13%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does OrthoPediatrics Corp (KIDS) report earnings?
OrthoPediatrics Corp (KIDS) is schdueled to report earning on Jul 30, 2025, TBA Not Confirmed.
    What is OrthoPediatrics Corp (KIDS) earnings time?
    OrthoPediatrics Corp (KIDS) earnings time is at Jul 30, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is KIDS EPS forecast?
          KIDS EPS forecast for the fiscal quarter 2025 (Q2) is -0.29.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis